vs
National CineMedia, Inc.（NCMI）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是National CineMedia, Inc.的1.1倍（$69.8M vs $63.4M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 2.5%，领先381.5%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 1.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -16.4%）
国家影院传媒是一家美国影院广告企业，依托由AMC、喜满客、 regal等头部连锁影院及区域影院院线组成的影院数字化网络，面向美国消费者，在影院场地、线上渠道以及移动端开展影院广告业务，是美国影院广告领域的核心运营商。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NCMI vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$63.4M
营收增速更快
RIGL
高出19.6%
1.6%
净利率更高
RIGL
高出381.5%
2.5%
两年增速更快
RIGL
近两年复合增速
-16.4%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.4M | $69.8M |
| 净利润 | $1.6M | $268.1M |
| 毛利率 | 95.0% | 91.5% |
| 营业利润率 | -2.8% | 33.2% |
| 净利率 | 2.5% | 384.0% |
| 营收同比 | 1.6% | 21.2% |
| 净利润同比 | 144.4% | 1769.2% |
| 每股收益（稀释后） | $0.02 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NCMIRIGL
| Q4 25 | — | $69.8M | ||
| Q3 25 | $63.4M | $69.5M | ||
| Q2 25 | $51.8M | $101.7M | ||
| Q1 25 | $34.9M | $53.3M | ||
| Q4 24 | $86.3M | $57.6M | ||
| Q3 24 | $62.4M | $55.3M | ||
| Q2 24 | $54.7M | $36.8M | ||
| Q1 24 | $37.4M | $29.5M |
净利润NCMIRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $1.6M | $27.9M | ||
| Q2 25 | $-10.7M | $59.6M | ||
| Q1 25 | $-30.7M | $11.4M | ||
| Q4 24 | $24.7M | $14.3M | ||
| Q3 24 | $-3.6M | $12.4M | ||
| Q2 24 | $-8.7M | $-1.0M | ||
| Q1 24 | $-34.7M | $-8.2M |
毛利率NCMIRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | 95.0% | 93.2% | ||
| Q2 25 | 93.8% | 95.6% | ||
| Q1 25 | 91.1% | 91.7% | ||
| Q4 24 | 96.4% | 89.9% | ||
| Q3 24 | 94.7% | 85.5% | ||
| Q2 24 | 93.2% | 92.4% | ||
| Q1 24 | 90.4% | 93.1% |
营业利润率NCMIRIGL
| Q4 25 | — | 33.2% | ||
| Q3 25 | -2.8% | 40.9% | ||
| Q2 25 | -23.2% | 60.1% | ||
| Q1 25 | -68.5% | 23.9% | ||
| Q4 24 | 23.2% | 28.9% | ||
| Q3 24 | -12.0% | 25.4% | ||
| Q2 24 | -17.0% | 1.2% | ||
| Q1 24 | -60.7% | -23.6% |
净利率NCMIRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 2.5% | 40.2% | ||
| Q2 25 | -20.7% | 58.6% | ||
| Q1 25 | -88.0% | 21.5% | ||
| Q4 24 | 28.6% | 24.9% | ||
| Q3 24 | -5.8% | 22.5% | ||
| Q2 24 | -15.9% | -2.8% | ||
| Q1 24 | -92.8% | -27.9% |
每股收益（稀释后）NCMIRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | $0.02 | $1.46 | ||
| Q2 25 | $-0.11 | $3.28 | ||
| Q1 25 | $-0.32 | $0.63 | ||
| Q4 24 | $0.26 | $0.82 | ||
| Q3 24 | $-0.04 | $0.70 | ||
| Q2 24 | $-0.09 | $-0.06 | ||
| Q1 24 | $-0.36 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $29.9M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $350.5M | $391.5M |
| 总资产 | $451.9M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NCMIRIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | $29.9M | $137.1M | ||
| Q2 25 | $37.2M | $108.4M | ||
| Q1 25 | $59.8M | $77.1M | ||
| Q4 24 | $75.2M | $77.3M | ||
| Q3 24 | $49.5M | $61.1M | ||
| Q2 24 | $53.8M | $49.1M | ||
| Q1 24 | $57.1M | $49.5M |
总债务NCMIRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益NCMIRIGL
| Q4 25 | — | $391.5M | ||
| Q3 25 | $350.5M | $117.6M | ||
| Q2 25 | $350.0M | $81.9M | ||
| Q1 25 | $370.8M | $18.6M | ||
| Q4 24 | $411.2M | $3.3M | ||
| Q3 24 | $385.5M | $-14.6M | ||
| Q2 24 | $387.9M | $-29.9M | ||
| Q1 24 | $402.3M | $-31.7M |
总资产NCMIRIGL
| Q4 25 | — | $513.6M | ||
| Q3 25 | $451.9M | $242.5M | ||
| Q2 25 | $462.0M | $206.7M | ||
| Q1 25 | $503.8M | $176.0M | ||
| Q4 24 | $568.6M | $164.0M | ||
| Q3 24 | $526.1M | $139.4M | ||
| Q2 24 | $527.2M | $128.4M | ||
| Q1 24 | $538.6M | $126.5M |
负债/权益比NCMIRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.0M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-2.0M | — |
| 自由现金流率自由现金流/营收 | -3.2% | — |
| 资本支出强度资本支出/营收 | 1.6% | — |
| 现金转化率经营现金流/净利润 | -0.63× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $24.8M | — |
8季度趋势，按日历期对齐
经营现金流NCMIRIGL
| Q4 25 | — | $22.0M | ||
| Q3 25 | $-1.0M | $24.0M | ||
| Q2 25 | $-4.9M | $30.5M | ||
| Q1 25 | $6.0M | $-893.0K | ||
| Q4 24 | $30.5M | $14.5M | ||
| Q3 24 | $-2.0M | $21.7M | ||
| Q2 24 | $7.7M | $302.0K | ||
| Q1 24 | $24.1M | $-5.0M |
自由现金流NCMIRIGL
| Q4 25 | — | — | ||
| Q3 25 | $-2.0M | — | ||
| Q2 25 | $-6.6M | — | ||
| Q1 25 | $5.3M | — | ||
| Q4 24 | $28.1M | — | ||
| Q3 24 | $-2.6M | — | ||
| Q2 24 | $6.4M | — | ||
| Q1 24 | $22.6M | — |
自由现金流率NCMIRIGL
| Q4 25 | — | — | ||
| Q3 25 | -3.2% | — | ||
| Q2 25 | -12.7% | — | ||
| Q1 25 | 15.2% | — | ||
| Q4 24 | 32.6% | — | ||
| Q3 24 | -4.2% | — | ||
| Q2 24 | 11.7% | — | ||
| Q1 24 | 60.4% | — |
资本支出强度NCMIRIGL
| Q4 25 | — | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 3.3% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 4.0% | — |
现金转化率NCMIRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | -0.63× | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 1.23× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NCMI
| National Advertising Revenue | $49.9M | 79% |
| Local Advertising Revenue | $9.6M | 15% |
| Founding Member Advertising Revenue From Beverage Concessionaire Agreements | $3.9M | 6% |
RIGL
暂无分部数据
